Michael Glantz

14.5k total citations · 4 hit papers
183 papers, 9.0k citations indexed

About

Michael Glantz is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Michael Glantz has authored 183 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pulmonary and Respiratory Medicine, 93 papers in Genetics and 66 papers in Oncology. Recurrent topics in Michael Glantz's work include Glioma Diagnosis and Treatment (92 papers), Brain Metastases and Treatment (86 papers) and Lung Cancer Research Studies (29 papers). Michael Glantz is often cited by papers focused on Glioma Diagnosis and Treatment (92 papers), Brain Metastases and Treatment (86 papers) and Lung Cancer Research Studies (29 papers). Michael Glantz collaborates with scholars based in United States, Switzerland and India. Michael Glantz's co-authors include Marc C. Chamberlain, Bernard F. Cole, Lawrence D. Recht, Alixis Van Horn, Andrew Lekos, S. Clifford Schold, Kurt A. Jaeckle, Patrick Y. Wen, Akshal Patel and Ephraim W. Church and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michael Glantz

173 papers receiving 8.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of the Extent of Resection With Survival in Glioblastoma

2016 707 citations Akshal Patel, Michael Glantz et al. profile →
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]

2000 537 citations Michael Glantz, Bernard F. Cole et al. Neurology profile →
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis

2016 314 citations Ming Yin, Monika Joshi et al. The Oncologist profile →
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression

2020 302 citations Patricia Yee, Tong Lu et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Glantz	4.3k	3.8k	2.4k	1.7k	1.4k	183	9.0k
Rolf‐Dieter Kortmann	5.0k 1.2×	3.6k 1.0×	2.1k 0.9×	1.8k 1.1×	1.9k 1.3×	227	8.2k
Normand Laperrière	5.7k 1.3×	4.0k 1.1×	1.6k 0.7×	2.0k 1.2×	2.2k 1.5×	280	10.2k
François Doz	3.1k 0.7×	2.0k 0.5×	1.8k 0.7×	2.0k 1.2×	1.1k 0.8×	324	8.3k
William R. Shapiro	4.7k 1.1×	2.8k 0.7×	1.7k 0.7×	1.3k 0.8×	1.1k 0.8×	137	8.9k
Edward G. Shaw	6.9k 1.6×	6.1k 1.6×	2.1k 0.9×	2.4k 1.5×	3.4k 2.4×	217	12.3k
Jeffrey J. Olson	5.1k 1.2×	3.6k 1.0×	2.4k 1.0×	1.3k 0.8×	2.2k 1.6×	310	11.2k
Maria Werner‐Wasik	4.0k 0.9×	7.1k 1.9×	3.2k 1.3×	1.4k 0.8×	2.6k 1.9×	276	11.3k
Robert J. Weil	2.3k 0.5×	2.3k 0.6×	2.1k 0.9×	1.2k 0.7×	1.3k 0.9×	271	9.5k
Michael Bamberg	2.6k 0.6×	2.3k 0.6×	1.0k 0.4×	1.5k 0.9×	895 0.6×	179	6.9k
Yuta Shibamoto	2.1k 0.5×	5.5k 1.4×	2.4k 1.0×	1.5k 0.9×	1.5k 1.1×	563	11.2k

Countries citing papers authored by Michael Glantz

Since Specialization

Citations

This map shows the geographic impact of Michael Glantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Glantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Glantz more than expected).

Fields of papers citing papers by Michael Glantz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Glantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Glantz. The network helps show where Michael Glantz may publish in the future.

Co-authorship network of co-authors of Michael Glantz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Glantz. A scholar is included among the top collaborators of Michael Glantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Glantz. Michael Glantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mansouri, Alireza, Mark Tülchinsky, Sajid Ali, et al.. (2025). Intra-Ommaya reservoir administration technique affects cerebrospinal fluid drug distribution in patients with leptomeningeal metastases. Neuro-Oncology Practice. 12(5). 884–891. 1 indexed citations

Zacharia, Brad E., et al.. (2025). Medical Therapy Alone for Ommaya Reservoir–Associated Bacterial Meningitis: When It Works and When It Fails. Neurosurgery. 97(2). 380–386. 1 indexed citations

Ozair, Ahmad, Liz Salmi, Bethany M. Kwan, et al.. (2024). Health state utility assessment for low-grade glioma.. Journal of Clinical Oncology. 42(16_suppl). e14039–e14039.

Mikolajewicz, Nicholas, Patricia Yee, Alexandra Miller, et al.. (2024). Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application. Journal of Clinical Oncology. 42(16). 1961–1974. 13 indexed citations

Lu, Tong, Patricia Yee, Stephen Y. Chih, et al.. (2024). LC3-associated phagocytosis of neutrophils triggers tumor ferroptotic cell death in glioblastoma. The EMBO Journal. 43(13). 2582–2605. 12 indexed citations

Darabi, Sourat, Joanne Xiu, Santosh Kesari, et al.. (2023). Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. Medical Oncology. 40(7). 197–197. 10 indexed citations

Mikolajewicz, Nicholas, Shahbaz Khan, Sheila Mansouri, et al.. (2022). Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies. Neuro-Oncology Advances. 4(1). vdac161–vdac161. 10 indexed citations

Boire, Adrienne, Dieta Brandsma, Priscilla K. Brastianos, et al.. (2019). Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro-Oncology. 21(5). 571–584. 107 indexed citations

Kalinina, Juliya, Jun Young Ahn, Narra S. Devi, et al.. (2016). Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clinical Cancer Research. 22(24). 6256–6265. 52 indexed citations

10.

Yin, Ming, Monika Joshi, Richard P. Meijer, et al.. (2016). Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis. The Oncologist. 21(6). 708–715. 314 indexed citations breakdown →

11.

Patel, Akshal, Varun V. Prabhu, David T. Dicker, et al.. (2014). COX-2 Drives Metastatic Breast Cells from Brain Lesions into the Cerebrospinal Fluid and Systemic Circulation. Cancer Research. 74(9). 2385–2390. 15 indexed citations

12.

Patel, Akshal, Gary Gronseth, & Michael Glantz. (2014). Carotid Artery Stenosis And Randomized Controlled Trials - Should We Abandon The Gold Standard (P7.170). Neurology. 82(10_supplement). 1 indexed citations

13.

Melisko, Michelle, Michael Glantz, & Hope S. Rugo. (2008). New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nature Clinical Practice Oncology. 6(1). 25–33. 32 indexed citations

14.

Chamberlain, Marc C., et al.. (2001). Adult medulloblastoma: Multiagent chemotherapy. Neuro-Oncology. 3(1). 29–34. 60 indexed citations

15.

Glantz, Michael, Hak Choy, Lisa Glantz, et al.. (1998). Histologic evidence of a radiosensitizing effect of Taxol in patients with astrocytomas. Journal of Neuro-Oncology. 39(3). 245–251. 15 indexed citations

16.

Glantz, Michael, H. Choy, Wallace Akerley, et al.. (1997). Weekly paclitaxel with and without concurrent radiation therapy: Toxicity, pharmacokinetics, and response. Seminars in Radiation Oncology. 7. 7 indexed citations

17.

Rhodes, C. Harker, Michael Glantz, Lisa Glantz, et al.. (1996). A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer. 77(3). 543–548. 3 indexed citations

18.

Choy, H., et al.. (1996). Concurrent Paclitaxel and Radiation Therapy for Solid Tumors. Cancer Control. 3(4). 310–318. 14 indexed citations

19.

Steiner, Marie E., Michael Glantz, & Andrew Lekos. (1995). Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. American Journal of Clinical Nutrition. 62(6). 1381S–1384S. 77 indexed citations

20.

Friedberg, Marc H. & Michael Glantz. (1994). Transdermal scopolamine-induced neurologic deficits in patients with cancer.. PubMed. 77(5). 141–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact